119 related articles for article (PubMed ID: 37800780)
1. Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: A SEER database analysis.
Xing H; Wu C; Zhang D; Zhang X
Medicine (Baltimore); 2023 Oct; 102(40):e35104. PubMed ID: 37800780
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.
Yao H; Shi H; Fan M; Yuan L; Lin R
Oxid Med Cell Longev; 2023; 2023():3619306. PubMed ID: 36825080
[TBL] [Abstract][Full Text] [Related]
3. Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.
He J; Wang S; Liu H; Duan C; Zhang H; Wen F; Zhang C
Transl Cancer Res; 2023 Dec; 12(12):3591-3603. PubMed ID: 38192997
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis.
Sun S; Wang W; He C
Oxid Med Cell Longev; 2021; 2021():9985814. PubMed ID: 34257826
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study.
Wang S; Ge C; Zhang J
J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005419
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Cardiovascular-Specific Mortality in Patients With Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Study.
Alhadeethi A; Atia A; Alkhawaldeh IM; Ibrahim AA; Afifi E; Elwekel A; Nouh A; Morsi MH
Cureus; 2023 Dec; 15(12):e51279. PubMed ID: 38288190
[TBL] [Abstract][Full Text] [Related]
7. Primary site as a novel prognostic factor for cardiovascular mortality post-radiotherapy in limited-stage small cell lung cancer: A large population-based study.
Zhao Y; Qin F; Ji Q; Xia W; He B
Front Cardiovasc Med; 2022; 9():922811. PubMed ID: 36035954
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
9. Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer.
Chen C; Xu F; Yuan S; Zhao X; Qiao M; Han D; Lyu J
Cancer Med; 2023 Feb; 12(3):2179-2186. PubMed ID: 35920057
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular-specific mortality among multiple myeloma patients: a population-based study.
Yin X; Fan F; Zhang B; Hu Y; Sun C
Ther Adv Hematol; 2022; 13():20406207221086755. PubMed ID: 35387110
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
13. Is sublobar resection sufficient for carcinoid tumors?
Yendamuri S; Gold D; Jayaprakash V; Dexter E; Nwogu C; Demmy T
Ann Thorac Surg; 2011 Nov; 92(5):1774-8; discussion 1778-9. PubMed ID: 21704299
[TBL] [Abstract][Full Text] [Related]
14. Risk of Cardiovascular Death in Osteosarcoma.
Jia Y; Xiong Y; Peng Z; Wang G
J Coll Physicians Surg Pak; 2023 Mar; 33(3):266-269. PubMed ID: 36945154
[TBL] [Abstract][Full Text] [Related]
15. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
[TBL] [Abstract][Full Text] [Related]
16. Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
Al-Kindi SG; Abu-Zeinah GF; Kim CH; Hejjaji V; William BM; Caimi PF; Oliveira GH
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):748-52. PubMed ID: 26324747
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
18. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Sun X; Men Y; Wang J; Bao Y; Yang X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2021 May; 12(9):1358-1365. PubMed ID: 33728811
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study.
He QS; Wang ZP; Li ZJ; Zhou P; Lian CL; Wu SG; Chen SF
Radiat Oncol; 2021 Sep; 16(1):185. PubMed ID: 34544466
[TBL] [Abstract][Full Text] [Related]
20. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
